Harrison Leila, Puri Mahesh, Greene Foster Diana, Karkia Sunita, Diamond-Smith Nadia G
Centre for Global Child Health, The Hospital for Sick Children, Toronto, Canada.
Center for Research on Environment, Health and Population Activities (CREHPA), Kathmandu, Nepal.
PLOS Glob Public Health. 2024 May 9;4(5):e0003144. doi: 10.1371/journal.pgph.0003144. eCollection 2024.
Abortion was legalized in Nepal in 2002; however, despite evidence of safety and quality provision of medical abortion (MA) pills by pharmacies in Nepal and elsewhere, it is still not legal for pharmacists to provide medication abortion in Nepal. However, pharmacies often do provide MA, but little is known about who seeks abortions from pharmacies and their experiences and outcomes. The purpose of this study is to understand the experiences of women seeking MA from a pharmacy, abortion complications experienced, and predictors for denial of MA. Data was collected from women seeking MA from four pharmacies in two districts of Nepal in 2021-2022. Data was collected at baseline (N = 153) and 6 weeks later (N = 138). Using descriptive results and multi-variable regression models, we explore differences between women who received and did not receive MA and predictors of denial of services. Most women requesting such pills received MA (78%), with those who were denied most commonly reporting denial due to the provider saying they were too far along. There were few socio-demographic differences between groups, with the exception of education and gestational age. Women reported receiving information on how to take pills and what to do about side effects. Just under half (45%) of women who took pills reported no adverse symptoms after taking them and only 13% sought care. Most women seeking MA from pharmacists in Nepal are receiving services, information, and having few post-abortion symptoms. This study expands the previous limited research on pharmacy provision of MA in Nepal using a unique dataset that recruits women at the time of abortion seeking and follows them over time, overcoming potential biases present in other study designs. This suggests that expansion of the law to allow pharmacy distribution would increase accessibility and reflect current practice.
2002年,尼泊尔将堕胎合法化;然而,尽管有证据表明尼泊尔及其他地方的药店能够安全、高质量地提供药物流产(MA)药,但在尼泊尔,药剂师提供药物流产服务仍然不合法。不过,药店经常会提供药物流产药,但对于哪些人从药店寻求堕胎服务以及他们的经历和结果却知之甚少。本研究的目的是了解从药店寻求药物流产服务的女性的经历、经历的流产并发症以及被拒绝提供药物流产服务的预测因素。2021年至2022年期间,从尼泊尔两个地区的四家药店寻求药物流产服务的女性中收集了数据。在基线时(N = 153)和6周后(N = 138)收集了数据。我们使用描述性结果和多变量回归模型,探讨了接受和未接受药物流产服务的女性之间的差异以及服务被拒绝的预测因素。大多数请求此类药物的女性获得了药物流产服务(78%),那些被拒绝的女性最常报告的原因是提供者称她们怀孕时间太长。除了教育程度和孕周外,不同组之间几乎没有社会人口统计学差异。女性报告收到了关于如何服药以及如何应对副作用的信息。服药的女性中,不到一半(45%)报告服药后没有出现不良症状,只有13%的人寻求医疗护理。在尼泊尔,大多数从药剂师那里寻求药物流产服务的女性都获得了服务、信息,且流产后症状较少。本研究利用一个独特的数据集扩展了此前关于尼泊尔药店提供药物流产服务的有限研究,该数据集在女性寻求堕胎时招募她们,并对其进行长期跟踪,克服了其他研究设计中存在的潜在偏差。这表明扩大法律允许药店分发药物流产药将提高可及性并反映当前的实际情况。